Home/AEON Biopharma/Eric Carter, MD, PhD
EC

Eric Carter, MD, PhD

Board Member

AEON Biopharma

Therapeutic Areas

AEON Biopharma Pipeline

DrugIndicationPhase
ABP-450Episodic MigrainePhase 2